Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment
- 28 February 2013
- journal article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 39 (1) , 71-77
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Metabolic and Cardiovascular Complications in HIV-Infected Patients: New Challenges for a New AgeThe Journal of Infectious Diseases, 2012
- First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional studyAIDS Research and Therapy, 2011
- Implementing operational research to scale-up access to antiretroviral therapy for HIV infection: lessons learned from the Cameroonian experienceCurrent Opinion in HIV and AIDS, 2011
- Hipertensión arterial, infección por el virus de la inmunodeficiencia humana y tratamiento antirretrovírico de gran actividadEnfermedades Infecciosas y Microbiología Clínica, 2010
- Lipoatrophy and lipohypertrophy are independently associated with hypertension*HIV Medicine, 2009
- Bioelectrical Impedance and Body Composition: Present Status and Future DirectionsNutrition Reviews, 2009
- Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adultsAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Impact of highly active antiretroviral therapy on blood pressure in HIV‐infected patients. A prospective study in a cohort of naive patientsHIV Medicine, 2005
- Effect of Antiretroviral Therapy on Lipid Metabolism in HIV/AIDS Subjects in CameroonJournal of Medical Sciences, 2005
- How to measure insulin action in vivoDiabetes/Metabolism Research and Reviews, 1994